Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Go back to Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Guardant Health (GH) Tops Q1 EPS by 26c, Updates Guidance

April 30, 2025 4:16 PM EDT

Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.49), $0.26 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $203.5 million versus the consensus estimate of $190.01 million.

GUIDANCE:

Guardant Health sees FY2025 revenue of $880-890 million, versus the consensus of... More